Live cold-adapted influenza A vaccine produced in Vero cell line

Virus Research

Volumn 103, Issue 1-2, 2004, Pages 187-193

  Romanova, Julia ^a   Katinger, Dietmar ^b   Ferko, Boris ^a   Vcelar, Brigitta ^b   Sereinig, Sabine ^a   Kuznetsov, Oleg ^c   Stukova, Marina ^c   Erofeeva, Marjana ^c   Kiselev, Oleg ^c   Katinger, Hermann ^a   Egorov, Andrej ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^b POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH   (Austria)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Cold adaptation; Influenza; Vaccine; Vero cell line

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; LIVE VACCINE; SIALIDASE;

ANIMAL EXPERIMENT; CELL LINE; CERCOPITHECIDAE; CLINICAL TRIAL; COLD ACCLIMATIZATION; CONFERENCE PAPER; DRUG SAFETY; DRUG TOLERABILITY; EPIDEMIC; FERRET; GENETIC CODE; GENETIC REASSORTMENT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERTHERMIA; INFLUENZA; MOUSE; NONHUMAN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SIDE EFFECT; TEMPERATURE SENSITIVITY; VERO CELL; VIROGENESIS; VIRUS ISOLATION; VIRUS STRAIN; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANIMALS; CERCOPITHECUS AETHIOPS; COLD; FERRETS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; VACCINATION; VACCINES, ATTENUATED; VERO CELLS; VIRUS REPLICATION;

ANIMALIA; CERCOPITHECUS AETHIOPS; MUSTELA;

EID: 2442466636     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.02.032     Document Type: Conference Paper

References (33)

1. Alexandrova G.I., Budilovsky G.N., Koval T.A., Polezhaev F.I., Garmashova L.M., Ghendon Y.Z., Romanova Y.R., Smorodintsev A.A. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Vaccine. 4:1986;114-118
2. Alymova I.V., Kodihalli S., Govorkova E.A., Fanget B., Gerdil C., Webster R.G. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs. J. Virol. 72:1998;4472-7447
3. Azzi A., Bartolomei-Corsi O., Zakrzewska K., Corcoran T., Newman R., Robertson J.S., Yates P., Oxford J.S. The haemagglutinins of influenza A (H1N1) viruses in the 'O' or 'D' phases exhibit biological and antigenic differences. Epidemiol. Infect. 111:1993;135-142
4. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., Bernstein D.I., Hayden F.G., Kotloff K., Zangwill K., Iacuzio D., Wolff M. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N. Engl. J. Med. 338:1998;1405-1412
5. Boyce T.G., Poland G.A. Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review. Biomed. Pharmacother. 54:2000;210-218
6. Cox N.J., Kitame F., Kendal A.P., Maassab H.F., Naeve C. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology. 167:1988;554-567
7. Edwards K.M., Dupont W.D., Westrich M.K., Plummer W.D. Jr., Palmer P.S., Wright P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J. Infect. Dis. 169:1994;68-76
8. Gambaryan A.S., Robertson J.S., Matrosovich M.N. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology. 258:1999;232-239
9. Glezen W.P., Payne A.A., Snyder N.D., Downs T.D. Mortality and influenza. J. Infect. Dis. 146:1982;313-321
10. Gorse G.J., Otto E.E., Powers D.C., Chambers G.W., Eickhoff C.S., Newman F.K. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J. Infect. Dis. 173:1996;285-290
11. Halperin S.A., Smith B., Mabrouk T., Germain M., Trepanier P., Hassell T., Treanor J., Gauthier R., Mills E.L. Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine. 20:2002;1240-12477
12. Katz J.M., Naeve C.W., Webster R.G. Host cell-mediated variation in H3N2 influenza viruses. Virology. 156:1987;386-395
13. Katz J.M., Webster R.G. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J. Infect. Dis. 160:1989;191-198
14. Katz J.M., Wang M., Webster R.G. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J. Virol. 64:1990;1808-1811
15. Kendal A.P., Maassab H.F., Alexandrova G.I., Ghendon Y.Z. Development of cold-adapted recombinant live, attenuated influenza A vaccines in the U.S.A. and U.S.S.R. Antiviral Res. 1:1981;339-365
16. Kendal A.P. Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries? Eur. J. Epidemiol. 13:1997;591-609
17. Klimov A.I., Cox N.J., Yotov W.V., Rocha E., Alexandrova G.I., Kendal A.P. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology. 186:1992;795-797
18. Kistner O., Barrett P.N., Mundt W., Reiter M., Schober-Bendixen S., Dorner F. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine. 16:1998;960-968
19. Liu T., Ye Z. Restriction of viral replication by mutation of the influenza virus matrix protein. J. Virol. 76:2002;13055-13061
20. Maassab H.F. Biologic and immunologic characteristics of cold-adapted influenza virus. J. Immunol. 102:1969;728-732
21. Maassab H.F., Bryant M.L. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev. Med. Virol. 9:1999;237-244
22. Parkin N.T., Chiu P., Coelingh K.L. Temperature sensitive mutants of influenza A virus generated by reverse genetics and clustered charged to alanine mutagenesis. Virus Res. 46:1996;31-44
23. Powers D.C., Murphy B.R., Fries L.F., Adler W.H., Clements M.L. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies. J. Am. Geriatr. Soc. 40:1992;163-167
24. Robertson J.S., Naeve C.W., Webster R.G., Bootman J.S., Newman R., Schild G.C. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology. 143:1985;166-174
25. Robertson J.S., Bootman J.S., Nicolson C., Major D., Robertson E.W., Wood J.M. The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology. 179:1990;35-40
26. Robertson J.S., Nicolson C., Bootman J.S., Major D., Robertson E.W., Wood J.M. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. J. Gen. Virol. 72:1991;2671-2677
27. Romanova J., Katinger D., Ferko B., Voglauer R., Mochalova L., Bovin N., Lim W., Katinger H., Egorov A. Dinstinct host range of influenza H3N2 virus isolates in Vero and MDCK cells determined by cell specific glycosylation pattern. Virology. 307:2003;90-97
28. Rudenko L.G., Slepushkin A.N., Monto A.S., Kendal A.P., Grigorieva E.P., Burtseva E.P., Rekstin A.R., Beljaev A.L., Bragina V.E., Cox N., et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J. Infect. Dis. 168:1993;881-887
29. Rudenko L.G., Arden N.H., Grigorieva E., Naychin A., Rekstin A., Klimov A.I., Donina S., Desheva J., Holman R.C., DeGuzman A., Cox N.J., Katz J.M. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine. 19:2000;308-318
30. Ryan D.M., Ticehurst J., Dempsey M.H. GG167 (4-guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob. Agents Chemother. 39:1995;2583-2594
31. Schild G.C., Oxford J.S., de Jong J.C., Webster R.G. Evidence for host-cell selection of influenza virus antigenic variants. Nature. 303:1983;706-709
32. Treanor J.J., Betts R.F. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects. Vaccine. 16:1998;1756-1760
33. Wood J.M., Oxford J.S., Dunleavy U., Newman R.W., Major D., Robertson J.S. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology. 171:1989;214-221